Patient characteristics
| Characteristic . | Treatment-naive patients (n = 44) . | Refractory patients (n = 23) . |
|---|---|---|
| Men/women, n/n | 22/22 | 8/15 |
| Median age at treatment, y (range) | 32 (2-68) | 34 (6-63) |
| Etiology | ||
| Idiopathic | 35 | 22 |
| Drug | 1 | 0 |
| Hepatitis | 6 | 0 |
| Epstein-Barr virus | 1 | 0 |
| Pregnancy | 1 | 0 |
| Chemical | 0 | 1 |
| Neutrophil count, ×109 cells/L | 0.24 | 0.29 |
| SAA/VSAA | 24/20 | 17/6 |
| Characteristic . | Treatment-naive patients (n = 44) . | Refractory patients (n = 23) . |
|---|---|---|
| Men/women, n/n | 22/22 | 8/15 |
| Median age at treatment, y (range) | 32 (2-68) | 34 (6-63) |
| Etiology | ||
| Idiopathic | 35 | 22 |
| Drug | 1 | 0 |
| Hepatitis | 6 | 0 |
| Epstein-Barr virus | 1 | 0 |
| Pregnancy | 1 | 0 |
| Chemical | 0 | 1 |
| Neutrophil count, ×109 cells/L | 0.24 | 0.29 |
| SAA/VSAA | 24/20 | 17/6 |